Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPRENAVIR vs ANDEXANET ALFA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMPRENAVIR vs ANDEXANET ALFA: Safety Overview

Metric AMPRENAVIR ANDEXANET ALFA
Total FAERS Reports 109 1,074
Deaths Reported 4 546
Death Rate 3.7% 50.8%
Hospitalizations 16 187
Average Patient Age 44.0 yrs 78.2 yrs
% Female Patients 25.0% 41.8%
FDA Approval Date Apr 15, 1999 N/A
Manufacturer N/A AstraZeneca Pharmaceuticals LP
Route N/A INTRAVENOUS
Marketing Status Discontinued N/A